Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2005-001991-11-DE
EUCTR2005-001991-11-DE
Active, not recruiting
Phase 1

Effekte von Escitalopram auf Aufmerksamkeit und kognitive Funktionen bei gesunden Probanden - Escitalopram

niversity of Aachen0 sites100 target enrollmentOctober 13, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsCipralex 10mg

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Aachen
Enrollment
100
Status
Active, not recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 13, 2005
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Male

Investigators

Sponsor
niversity of Aachen

Eligibility Criteria

Inclusion Criteria

  • •100 gesunde, männliche Nichtraucher im Alter von 18 \- 45 Jahren.
  • •Keine psychiatrische Erkrankung in der Vorgeschichte.
  • •Mindestens vierwöchige Medikamentenfreiheit.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Psychische Erkrankungen.
  • •Relevante körperliche Erkrankungen.
  • •Unmöglichkeit zur Durchführung einer MR\-Untersuchung (z.B. Metall\-Implantate).

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Evaluation of the effect of escitalopram on cognitive and fine motor function in depressed elderly patients.
EUCTR2006-002411-27-BEniversitair Psychiatrisch Centrum KU Leuven40
Completed
Phase 3
The effect of treatment with escitalopram on quality of life and hospitalization rate in depressed patients with systolic heart failureheart failure.Heart failure
IRCT20230510058142N1Shahid Beheshti University of Medical Sciences84
Not yet recruiting
Phase 4
A clinical trial to study the effect of Escitalopram with and without Mindfulness-based therapy in patients who develop depression and anxiety after suffering from a heart attackHealth Condition 1: I219- Acute myocardial infarction, unspecified
CTRI/2024/03/063401eha Mittal
Completed
Phase 3
Escitalopram ?s effectiveness on treatment of depressive disorder and improvement of quality of life in patients who are undergone coronary artery bypass graft surgery
IRCT20140126016374N2niversity of social welfare and rehabilitation sciences50
Completed
Phase 2
Evaluation of the effect of Escitalopram versus placebo trial on changing the neuroticismeuroticism or neuroticism.Post-traumatic stress disorder, acuteF43.11
IRCT20211208053331N1Ahvaz University of Medical Sciences172